- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/08 - Antiallergic agents
Patent holdings for IPC class A61P 37/08
Total number of patents in this class: 3608
10-year publication summary
118
|
122
|
210
|
254
|
216
|
253
|
313
|
235
|
219
|
17
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Daiichi Sankyo Company, Limited | 1863 |
48 |
Société des Produits Nestlé S.A. | 9243 |
45 |
Regeneron Pharmaceuticals, Inc. | 3980 |
43 |
Taisho Pharmaceutical Co., Ltd. | 860 |
40 |
Novartis AG | 11276 |
34 |
Takeda Pharmaceutical Company Limited | 2945 |
30 |
Osaka University | 3296 |
29 |
Astellas Pharma Inc. | 1123 |
27 |
Shionogi & Co., Ltd. | 889 |
27 |
Dainippon Sumitomo Pharma Co., Ltd. | 214 |
26 |
Kyowa Hakko Kirin Co., Ltd. | 284 |
26 |
AstraZeneca AB | 2956 |
25 |
Ono Pharmaceutical Co., Ltd. | 435 |
25 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3352 |
24 |
Glaxo Group Limited | 4281 |
21 |
The Regents of the University of California | 19503 |
21 |
N.V. Nutricia | 1042 |
21 |
Kyoto University | 2777 |
19 |
Mitsubishi Tanabe Pharma Corporation | 576 |
19 |
Nestec S.A. | 2709 |
18 |
Other owners | 3040 |